NCT06454890View on ClinicalTrials.gov

Clinical Study of Trop2 CAR-NK in the Treatment of Relapsed/Refractory Non-Small Cell Lung Cancer (NSCLC)

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2029

Conditions

Non-Small Cell Lung Cancer NSCLC

Interventions

BIOLOGICAL

Anti-Trop2 CAR-NK cell

chemotherapy followed by Trop2 CAR-NK infusion

All Listed Sponsors

lead

Henan Cancer Hospital

OTHER_GOV